-
Candida krusei-Induced Apoptosis in Mammary Cells
2026-09-22
The 2023 Animals study shows that Candida krusei yeast and hypha phases both trigger apoptosis in bovine mammary epithelial cells, but through different dominant routes. Its phase-resolved co-culture design links yeast-associated mitochondrial injury with hypha-associated death ligand/receptor signaling and implicates TLR2/ERK and JNK/ERK networks in the host response.
-
Topotecan HCl: DNA Damage Assay Workflows
2026-09-21
Topotecan HCl enables controlled studies of replication-associated DNA damage, apoptosis, tumor-cell depletion, and treatment scheduling across cancer models. This guide connects practical dosing workflows with the DNA-damage-burden findings of a recent neuroinflammation study while clearly separating validated oncology applications from exploratory assay extensions.
-
Bafilomycin A1: V-ATPase Inhibitor Workflow
2026-09-21
Bafilomycin A1 enables reversible, nanomolar perturbation of organelle acidification for lysosomal assays, osteoclast studies, pathogen-induced vacuolization, and exploratory centrosome research. This workflow connects established V-ATPase biology with the Kif9–centriolar satellite findings while clearly separating validated applications from hypothesis-generating extensions.
-
Carbenoxolone disodium Lab Workflow Guide
2026-09-20
Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used in cell, enzyme, or tissue workflows with matched-vehicle, viability, and orthogonal controls, rather than as a selective in vivo efficacy agent or definitive single-target probe.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-09-19
The Hoechst 33342/PI Double Staining Kit (K2237) helps researchers distinguish nuclear chromatin changes from loss of cell membrane integrity in cultured-cell death experiments. It is intended for scientific research workflows only and should not be used for diagnosis, medical testing, or clinical decision-making.
-
Nebivolol hydrochloride in Signaling and Yeast Assays
2026-09-19
Nebivolol hydrochloride provides a focused way to interrogate β1-adrenergic receptor signaling while also serving as a useful negative comparator in drug-sensitized yeast TOR assays. This article connects receptor pharmacology, assay design, compound handling, and troubleshooting without overstating what a yeast growth result can prove.
-
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-09-18
TBST is a buffered saline and non-ionic detergent solution used to reduce nonspecific binding during antibody-based assays. It is suitable for Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry, but detergent-sensitive workflows require separate compatibility validation.
-
Neuromedin S (rat): Practical GPCR Assay Guide
2026-09-18
Neuromedin S (rat) provides a defined peptide agonist for controlled activation of neuromedin U receptor signaling in rat-focused GPCR/G protein assays. It is intended for research workflows, not diagnostic, therapeutic, or medical use, and should be handled according to its stated solubility and storage limits.
-
Firefly Luciferase mRNA: Delivery & Assay Guide
2026-09-17
Use Firefly Luciferase mRNA as a sensitive, transient control for transfection, formulation screening, cell viability assay design, and in vivo imaging. This guide connects ARCA capping and modified nucleotides with practical handling, route-comparison experiments, and troubleshooting strategies.
-
Rimonabant (SR141716) in Pain Research
2026-09-17
Rimonabant (SR141716) provides a selective CB1 blockade strategy for separating endocannabinoid signaling from adenosine A2A-mediated analgesia in terpene studies. This workflow connects appetite regulation research with neuropathic pain, inflammation, immune signaling, and behavioral pharmacology while highlighting key controls for dose, vehicle, locomotion, and sex effects.
-
Programmed Cell Death in Heart Disease
2026-09-16
The 2012 review reframes cardiac cell injury by showing that both apoptosis and a substantial subset of necrotic deaths can be regulated, interconnected processes rather than strictly passive versus active outcomes. Its pathway-based analysis provides a useful framework for designing experiments that distinguish morphology, membrane integrity, energetic failure, inflammatory signaling, and upstream death mechanisms.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-15
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry workflows. It is intended for research use only; assay-specific titration and controls are required, and the reagent should not be used for diagnostic, therapeutic, or unvalidated live-cell applications.
-
Saquinavir: Biomimetic Permeability Workflows
2026-09-15
Saquinavir can serve as a mechanistically defined HIV protease inhibitor control while biomimetic chromatography helps characterize drug–membrane interactions. This workflow combines IAM-LC, OT-CEC, and MS to support antiretroviral drug research, permeability screening, and carefully bounded translational studies.
-
n-Dodecyl-β-D-maltoside for WecA Assays
2026-09-14
DDM provides a gentle, tunable route for extracting and stabilizing difficult multi-pass membrane proteins such as WecA while preserving a workable environment for kinetic analysis. This guide connects detergent screening, affinity purification, UMP-based activity measurements, and troubleshooting into an applied workflow for membrane protein research and inhibitor discovery.
-
MK 0893: Glucagon Receptor Antagonist Workflows
2026-09-14
MK 0893 is a competitive, reversible glucagon receptor antagonist for connecting GCGR binding, cAMP signaling, and glucose-response phenotypes. This workflow-focused guide covers assay setup, in vivo translation, selectivity controls, and troubleshooting for type 2 diabetes research.